Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Maria Cossu Rocca
Observed names:
M Cossu Rocca,
M. Cossu Rocca,
M. cossu rocca,
M.Cossu Rocca,
Maria cossu Rocca
Institution:
European Institute of Oncology
Observed institutions:
University of Milan,
Azienda Ospedaliera Universitaria Integrata Verona,
Candiolo Cancer Institute,
University of Turin,
European Institute of Oncology
ORCID:
0000-0002-5780-3774
Observed ORCID:
0000-0002-5780-3774
OpenAlex ID:
A5036999191
Prognostic Role of PD-L1 Expression in Renal Cell Carcinoma. A Systematic Review and Meta-Analysis
2015
·
Roberto Iacovelli
, Franco Nolè
, et al.
·
Targeted Oncology
·
190
Functional Genomics Uncover the Biology behind the Responsiveness of Head and Neck Squamous Cell Cancer Patients to Cetuximab
2016
·
Paolo Bossi
, Cristiana Bergamini
, et al.
·
Clinical Cancer Research
·
96
A randomized, double-blind, placebo-controlled, multicenter study of a ginger extract in the management of chemotherapy-induced nausea and vomiting (CINV) in patients receiving high-dose cisplatin
2017
·
P. Bossi
, D. Cortinovis
, et al.
·
Annals of Oncology
·
95
PDF
Retrospective analysis of factors influencing oncologic outcome in 590 patients with early‐intermediate glottic cancer treated by transoral laser microsurgery
2016
·
Mohssen Ansarin
, Augusto Cattaneo
, et al.
·
Head & Neck
·
80
Hormone‐receptor expression and activity of trastuzumab with chemotherapy in HER2‐positive advanced breast cancer patients
2011
·
Filippo Montemurro
, Valentina Rossi
, et al.
·
Cancer
·
74
PDF
Concomitant chemoradiation (CRT) or cetuximab/RT (CET/RT) versus induction Docetaxel/ Cisplatin/5-Fluorouracil (TPF) followed by CRT or CET/RT in patients with Locally Advanced Squamous Cell Carcinoma of Head and Neck (LASCCHN). A randomized phase III factorial study (NCT01086826).
2014
·
Maria Grazia Ghi
, Adriano Paccagnella
, et al.
·
Journal of Clinical Oncology
·
70
Significance of PD-L1 in Metastatic Urothelial Carcinoma Treated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis
2024
·
Brigida Anna Maiorano
, Massimo Di Maio
, et al.
·
JAMA Network Open
·
67
Bisphosphonates and jaw osteonecrosis in patients with advanced breast cancer
2006
·
G. Sanna
, L. Preda
, et al.
·
Annals of Oncology
·
63
PDF
Combining standardized uptake value of FDG-PET and apparent diffusion coefficient of DW-MRI improves risk stratification in head and neck squamous cell carcinoma
2016
·
Lorenzo Preda
, Giorgio Conte
, et al.
·
European Radiology
·
48
Brain metastases in patients with advanced breast cancer.
2007
·
G Sanna
, L Franceschelli
, et al.
·
PubMed
·
44
Survival Outcomes in Oral Tongue Cancer: A Mono-Institutional Experience Focusing on Age
2021
·
Mohssen Ansarin
, Rita De Berardinis
, et al.
·
Frontiers in Oncology
·
40
PDF
The incidence and relative risk of cardiovascular toxicity in patients treated with new hormonal agents for castration-resistant prostate cancer
2015
·
Roberto Iacovelli
, Elena Verri
, et al.
·
European Journal of Cancer
·
39
Management of Germ Cell Tumors During the Outbreak of the Novel Coronavirus Disease-19 Pandemic: A Survey of International Expertise Centers
2020
·
Lucia Nappi
, Margaret Ottaviano
, et al.
·
The Oncologist
·
38
PDF
Radiation-induced acute dysphagia: Prospective observational study on 42 head and neck cancer patients
2017
·
D. Alterio
, M. A. Gerardi
, et al.
·
Strahlentherapie und Onkologie
·
35
Role of CT Perfusion in Monitoring and Prediction of Response to Therapy of Head and Neck Squamous Cell Carcinoma
2014
·
Lorenzo Preda
, Sonia Francesca Calloni
, et al.
·
BioMed Research International
·
32
PDF
Role of EGFR as prognostic factor in head and neck cancer patients treated with surgery and postoperative radiotherapy: proposal of a new approach behind the EGFR overexpression
2017
·
Daniela Alterio
, Giulia Marvaso
, et al.
·
Medical Oncology
·
28
Prevention and treatment of oral mucositis in patients with head and neck cancer treated with (chemo) radiation: report of an Italian survey
2014
·
Paolo Bossi
, Gianmauro Numico
, et al.
·
Supportive Care in Cancer
·
28
Metronomic administration of pegylated liposomal-doxorubicin in extensively pre-treated metastatic breast cancer patients: A mono-institutional case-series report
2009
·
E. Munzone
, A. Di Pietro
, et al.
·
The Breast
·
28
PDF
A role for the immune system in advanced laryngeal cancer
2020
·
Marta Tagliabue
, Fausto Maffini
, et al.
·
Scientific Reports
·
26
PDF
Prognostic significance of neutrophil‐to‐lymphocyte ratio in HPV status era for oropharyngeal cancer
2020
·
Giuseppe Fanetti
, Daniela Alterio
, et al.
·
Oral Diseases
·
26
Clinical outcomes and prognostic factors in recurrent and/or metastatic head and neck cancer patients treated with chemotherapy plus cetuximab as first-line therapy in a real-world setting
2019
·
Roberta Depenni
, Maria Cossu Rocca
, et al.
·
European Journal of Cancer
·
25
Oligo metastatic renal cell carcinoma: stereotactic body radiation therapy, if, when and how?
2021
·
G. Marvaso
, G. Corrao
, et al.
·
Clinical & Translational Oncology
·
23
Nutritional Intervention for Nonsurgical Head and Neck Cancer Patients Treated with Radiation Therapy: Results from a Prospective Stepped-Wedge Clinical Protocol
2018
·
Stefania Volpe
, Giulia Marvaso
, et al.
·
Nutrition and Cancer
·
22
Algorithm to predict postoperative complications in oropharyngeal and oral cavity carcinoma
2014
·
Luigi Santoro
, Marta Tagliabue
, et al.
·
Head & Neck
·
22
A phase II-III study comparing concomitant chemoradiotherapy (CRT) versus cetuximab/RT (CET/RT) with or without induction docetaxel/cisplatin/5-fluorouracil (TPF) in locally advanced head and neck squamous cell carcinoma (LASCCHN): Efficacy results (NCT01086826).
2013
·
Maria Grazia Ghi
, Adriano Paccagnella
, et al.
·
Journal of Clinical Oncology
·
22
Show more works
View as search
Works count:
130
Citation count:
1,692
H-index:
22
I10-index:
42
Year
Topic
Type